Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial

Thomas Zilli, Ciro Franzese, Marta Bottero, Niccolò Giaj-Levra, Robert Förster, Daniel Zwahlen, Nikolaos Koutsouvelis, Aurelie Bertaut, Julie Blanc, Giuseppe Roberto D'agostino, Filippo Alongi, Matthias Guckenberger, Marta Scorsetti, Raymond Miralbell

Research output: Contribution to journalArticlepeer-review

Abstract

The ONE SHOT trial is the first phase I/II prospective, multicenter, single-arm study assessing the efficacy and safety of a single-dose SBRT for men with localized prostate cancer. Aim of this paper is to present the phase I results of a 19 Gy single fraction urethra-sparing SBRT with real-time electromagnetic tracking.

Original languageEnglish
Pages (from-to)83-86
Number of pages4
JournalRadiotherapy and Oncology
Volume139
DOIs
Publication statusPublished - Oct 2019

Fingerprint Dive into the research topics of 'Single fraction urethra-sparing prostate cancer SBRT: Phase I results of the ONE SHOT trial'. Together they form a unique fingerprint.

Cite this